{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T17:29:56Z","timestamp":1760549396334},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,8,24]],"date-time":"2013-08-24T00:00:00Z","timestamp":1377302400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1007\/s00467-013-2591-8","type":"journal-article","created":{"date-parts":[[2013,8,23]],"date-time":"2013-08-23T19:37:06Z","timestamp":1377286626000},"page":"149-153","source":"Crossref","is-referenced-by-count":31,"title":["Eculizumab long-term therapy for pediatric renal transplant in aHUS with CFH\/CFHR1 hybrid gene"],"prefix":"10.1007","volume":"29","author":[{"given":"Elena","family":"Rom\u00e1n-Ortiz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Santiago","family":"Mendizabal Oteiza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheila","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margarita","family":"L\u00f3pez-Trascasa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pilar","family":"S\u00e1nchez-Corral","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Santiago","family":"Rodr\u00edguez de Cordoba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,8,24]]},"reference":[{"key":"2591_CR1","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/nrneph.2010.155","volume":"7","author":"J Zuber","year":"2011","unstructured":"Zuber J, Le Quintrect M, Sberro-Soussan R, Loirat C, Fremeaux-Bacchi V, Legendre C (2011) New insights into postrenal transplant hemolytic uremic syndrome. Nat Rev Nephrol 7:23\u201325","journal-title":"Nat Rev Nephrol"},{"key":"2591_CR2","doi-asserted-by":"crossref","first-page":"3337","DOI":"10.1111\/j.1600-6143.2012.04252.x","volume":"12","author":"J Zuber","year":"2012","unstructured":"Zuber J, Le Quintrect M, Krid S, Bertoye C, Gueutin V, Lahoche A, Heune N, Ardissino G, Chatelet V, No\u00ebl LH, Hourmant M, Niaudet P, Fremeaux-Bacchi V, Rondeau A, Legendre C, Loirat C (2012) Eculizumab for atypical hemolytic syndrome recurrence in renal transplantation. Am J Transplant 12:3337\u20133354","journal-title":"Am J Transplant"},{"key":"2591_CR3","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.molimm.2004.01.003","volume":"41","author":"P S\u00e1nchez-Corral","year":"2004","unstructured":"S\u00e1nchez-Corral P, Gonz\u00e1lez-Rubio C, Rodr\u00edguez de C\u00f3rdoba S, L\u00f3pez-Trascasa M (2004) Functional analysis in serum from atypical Hemolytic Uremic Syndrome patients reveals impaired protection of host cells associated with mutations in Factor H. Mol Immunol 41:81\u201384","journal-title":"Mol Immunol"},{"key":"2591_CR4","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.imbio.2012.07.021","volume":"217","author":"S Rodr\u00edguez de C\u00f3rdoba","year":"2012","unstructured":"Rodr\u00edguez de C\u00f3rdoba S, Tortajada A, Harris CL, Morgan P (2012) Complement dysregulation and disease: from genes and proteins to diagnostics and drugs. Immunobiology 217:1034\u20131046","journal-title":"Immunobiology"},{"key":"2591_CR5","doi-asserted-by":"crossref","first-page":"e431","DOI":"10.1371\/journal.pmed.0030431","volume":"3","author":"JP Venables","year":"2006","unstructured":"Venables JP, Strain L, Routledge D, Bourn D, Powell HM, Warwicker P, Diaz-Torres ML, Sampson A, Mead P, Webb M, Pirson Y, Jackson MS, Hughes A, Wood KM, Goodship JA, Goodship TH (2006) Atypical haemolytic uraemic syndrome associated with a hybrid complement gene. PLoS Med 3:e431","journal-title":"PLoS Med"},{"key":"2591_CR6","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1111\/j.1600-6143.2009.02817.x","volume":"9","author":"V Chatelet","year":"2009","unstructured":"Chatelet V, Fremeaux-Bacchi V, Lobbedez T, Ficheux M, Hurault de Ligny B (2009) Safety and long-term efficacy of eculizumab in a renal transplant patient with recurrent atypical hemolytic-uremic syndrome. Am J Transplant 9:2644\u20132645","journal-title":"Am J Transplant"},{"key":"2591_CR7","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1056\/NEJMc0809959","volume":"360","author":"RA Gruppo","year":"2009","unstructured":"Gruppo RA, Rother RP (2009) Eculizumab for congenital atypical hemolytic-uremic syndrome. N Eng J Med 360:544\u2013546","journal-title":"N Eng J Med"},{"key":"2591_CR8","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1111\/j.1600-6143.2012.04051.x","volume":"12","author":"S Krid","year":"2012","unstructured":"Krid S, Roumenina LT, Beury D, Charbit M, Boyer O, Fr\u00e9meaux-Bacchi V, Niaudet P (2012) Renal Transplantation Under Prophylactic Eculizumab in Atypical Hemolytic Uremic Syndrome with CFH\/CFHR1 Hybrid Protein. Am J Transplant 12:1938\u20131944","journal-title":"Am J Transplant"},{"key":"2591_CR9","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.2215\/CJN.10181110","volume":"6","author":"C Nester","year":"2011","unstructured":"Nester C, Stewart Z, Myers D (2011) Pre-emptive eculizumab and plasmapheresis for renal transplant in atypical hemolytic uremic syndrome. Clin J Am Soc Nephrol 6:1488\u20131494","journal-title":"Clin J Am Soc Nephrol"},{"key":"2591_CR10","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/ki.2011.291","volume":"81","author":"A Tortajada","year":"2012","unstructured":"Tortajada A, Pinto S, Mart\u00ednez-Ara J, L\u00f3pez-Trascasa M, S\u00e1nchez-Corral P, Rodr\u00edguez de C\u00f3rdoba S (2012) Complement factor H variants I890 and L1007 while commonly associated with atypical haemolytic uremic syndrome are polymorphisms with no functional significance. Kidney Int 81:56\u201363","journal-title":"Kidney Int"},{"key":"2591_CR11","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1093\/hmg\/ddi066","volume":"14","author":"E Esparza-Gordillo","year":"2005","unstructured":"Esparza-Gordillo E, Goicoechea de Jorge E, L\u00f3pez-Trascasa M, S\u00e1nchez-Corral P, Rodr\u00edguez de C\u00f3rdoba S (2005) Predisposition to atypical Hemolytic Uremic Syndrome involves the concurrence of different susceptibility alleles in the Regulators of Complement Activation gene cluster in 1q32. Hum Mol Genet 14:703\u2013712","journal-title":"Hum Mol Genet"},{"key":"2591_CR12","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1681\/ASN.2007080923","volume":"19","author":"R Martinez-Barricarte","year":"2008","unstructured":"Martinez-Barricarte R, Pianetti G, Gautard R, Misselwitz J, Strain L, Fremeaux-Bacchi V, Skerka C, Zipfel P, Goodship T, Noris M, Remuzzi G, Rodr\u00edguez de C\u00f3rdoba S, on behalf of the European Working Party on the Genetics of HUS (2008) The complement factor H R1210C mutation is associated with atypical hemolytic uremic syndrome. J Am Soc Nephrol 19:639\u2013646","journal-title":"J Am Soc Nephrol"},{"key":"2591_CR13","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/nrneph.2012.214","volume":"8","author":"J Zuber","year":"2012","unstructured":"Zuber J, Fakouri F, Roumenia L, Loirat C, Fremeaux-Bacchi V (2012) Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies. Nat Rev Nephrol 8:643\u2013657","journal-title":"Nat Rev Nephrol"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-013-2591-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00467-013-2591-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-013-2591-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T01:06:54Z","timestamp":1559092014000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00467-013-2591-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8,24]]},"references-count":13,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["2591"],"URL":"https:\/\/doi.org\/10.1007\/s00467-013-2591-8","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8,24]]}}}